Pulmonary Cell News Volume 15.14 | Jul 30 2026

    0
    18







    2026-07-30 | PULCN 15.14


    Pulmonary Cell News by STEMCELL Technologies
    Vol. 15.14 – 30 July, 2026
    TOP STORY

    Mechanisms and Therapeutic Targets in Distant Metastasis of Lung Adenocarcinoma

    In this study, digital spatial profiling, multiplex immunofluorescence, and clinical data from 52 lung adenocarcinoma patients were integrated to develop organ-specific metastasis risk models, and the molecular mechanisms underlying metastatic organotropism were investigated.
    [Signal Transduction and Targeted Therapy]

    Full Article
    Immunostained airway epithelial cells at the air-liquid interface with text describing a free on-demand course on pulmonary cell culture.
    PUBLICATIONSListed by the impact factor of the journal

    ADAMTS14 Is a Novel Modulator of Fibroblast Mechanoactivation in Pulmonary Fibrosis

    Investigators characterized the role of ADAM with Thrombospondin motifs 14 (ADAMTS14) in YAP-mediated fibroblast mechanoactivation and pulmonary fibrosis.
    [American Journal of Respiratory and Critical Care Medicine]

    Abstract

    Blocking Pyruvate Carboxylase Expression Triggers Ferroptosis and Inhibits Non-Small Cell Lung Cancer Progression

    Researchers identified pyruvate carboxylase as a pivotal ferroptosis regulator that is highly expressed in NSCLC tissues and associated with aggressive progression and poor prognosis.
    [Cancer Letters]

    Abstract

    N6-Methyladenosine-Mediated Upregulation of PAICS Promotes Lung-Adenocarcinoma Metastasis via the Integrin-FAK Signaling

    Scientists revealed that phosphoribosylaminoimidazole carboxylase/phosphoribosylaminoimidazole succinocarboxamide synthetase (PAICS) mRNA and protein levels were significantly increased in lung-adenocarcinoma tumor tissues compared to adjacent normal tissues.
    [Oncogene]

    Abstract

    Activation of the NF-κB/ALDH1A1 Signaling Promotes Non-Mutational Resistance to EGFR-TKIs in Non-Small Cell Lung Cancer

    The authors established tyrosine kinase inhibitor (TKI)-resistant variants by integrating cell lines, lung cancer organoids, and in vivo models, revealing the pivotal role of the NF-κB/ALDH1A1 signaling in mediating non-mutational TKI resistance.
    [Oncogene]

    Abstract | Graphical Abstract

    M2‑TAM‑Derived Exosomal miR‑491‑3p Modulates UBE2D3 and Promotes the Proliferation, Migration, and Invasion of Lung Cancer Cells

    M2‑like macrophages, IL‑4/IL‑13‑polarized THP‑1‑derived macrophages, were shown to release exosomes that lung cancer cells effectively internalized. These exosomes markedly enhanced the proliferation, migration, and invasion of lung cancer cells, thereby promoting malignancy.
    [Oncology Reports]

    Full Article
    REVIEWS

    Lung Cancer Stem Cells in the Tumor Microenvironment: Translational Biomarkers and Therapeutic Strategies for Immune Evasion and Treatment Resistance

    The authors frame lung cancer stem cells and the tumor immune microenvironment as a reciprocal regulatory network rather than as independent biological compartments.
    [Translational Oncology]

    Full Article | Graphical Abstract
    INDUSTRY AND POLICY NEWS

    FDA Approves Zidesamtinib for Lung Cancers With ROS1 Fusions, Based on MSK Research

    A new drug that treats NSCLC carrying a mutation called a ROS1 fusion has been approved by the US FDA. The drug zidesamtinib (Jideytro) was approved for patients with advanced ROS1-positive NSCLC who have stopped responding to other drugs aimed at ROS1.
    [Memorial Sloan Kettering Cancer Center]

    Press Release
    FEATURED EVENT

    ISEH 55th Annual Scientific Meeting

    August 27-30, 2026
    Frankfurt, Germany

    > See All Events

    JOB OPPORTUNITIES

    Faculty Positions – Cancer Research

    Thomas Jefferson University – Philadelphia, Pennsylvania, United States

    Physician Scientist – Cancer Research

    Dartmouth Cancer Center – Lebanon, New Hampshire, United States

    Postdoctoral Fellow – Cancer Prevention Fellowship Program

    CICF International, Inc. – Maryland, United States

    Postdoctoral Program – Integrated Science Lab

    UmeÃ¥ University – UmeÃ¥, Sweden

    Research Group Leader – Cardiopulmonary Molecular Biology

    Medical University of Vienna – Vienna, Austria

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2